Ticker Report StockNews.com initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX - Free Report) in a research note published on Tuesday morning. The brokerage issued a sell rating on the specialty...\n more…
Zolmax Tenax Therapeutics, Inc. (NASDAQ:TENX - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of...\n more…
Ticker Report StockNews.com initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX - Free Report) in a report published on Monday. The firm issued a sell rating on the specialty pharmaceutical company's...\n more…
Ticker Report Analysts at StockNews.com initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX - Get Free Report) in a research note issued on Sunday. The brokerage set a "sell" rating on the specialty...\n more…